Project ideas from Hacker News discussions.

Global review confirms mRNA vaccines are safe, effective and full of promise

📝 Discussion Summary (Click to expand)

1. Restarting risky research

“In 2017, the Trump administration restarted this dangerous research.” — petilon

2. Need for competent leadership

“If we want to solve that we need to stop enabling career politicians whose only life experience is debating.” — petterroea

“We would be a hell of a lot better off with career politicians than the current batch of grifters and ex‑Fox News chuckleheads.” — TylerE

3. Vaccine profit & legal immunity concerns

“Vaccines are wildly profitable.” — timr

“Also, the manufacturers can never be held responsible, because they have legal immunity for the COVID vaccines.” — api

4. Erosion of trust in regulators

“The problem with the recent (Tuesday) Supreme Court overturning of Humphreys Executor^ is that it makes Congressionally‑intended independent regulatory agencies (read: FDA) much more behold‑to and controllable‑by any current President.” — ethbr1

5. Misinformation & public perception

“You cannot reason a person out of a position they did not reason themselves into in the first place.” — binarycrusader


🚀 Project Ideas

Generating project ideas…

Transparent Adverse Event Tracker (TAET)

Summary

  • A secure, verified crowdsourced platform for reporting and analyzing vaccine and drug side‑effects, reducing noise in VAERS.
  • Core value: Turn raw reports into trustworthy, searchable data with built‑in causality tagging.

Details

Key Value
Target Audience Patients, clinicians, pharmacists, epidemiologists
Core Feature Verified event submission + AI‑assisted causality scoring + interactive risk dashboards
Tech Stack React frontend, Node/Express backend, PostgreSQL, GraphQL, AI models (HuggingFace), FHIR API
Difficulty Medium
Monetization Revenue-ready: Subscription SaaS for clinics ($15/mo)

Notes

  • HN commenters repeatedly cite “lack of reliable adverse‑event data” and “need to stop dismissing reports” (e.g., petilon: “If you dispute any of the above is factual please back up your assertion with citations.”). Providing a trustable, transparent system would directly address that frustration.
  • Could spark discussion around regulation of post‑market surveillance and improve public confidence.

Interactive Risk‑Benefit Visualizer for Public Health Recommendations

Summary

  • A web app that lets users explore the quantitative risk‑benefit trade‑offs of vaccines, medications, and interventions using real‑world data.
  • Core value: Empower individuals to see concrete numbers (e.g., hospitalization odds, myocarditis risk) instead of vague statements.

Details

Key Value
Target Audience General public, journalists, policymakers, educators
Core Feature Interactive sliders for demographic/health parameters; auto‑generated risk charts; citation pop‑ups
Tech Stack Vue.js, D3.js, Python (Flask), SQLite, OpenFDA API, MathJax
Difficulty Low
Monetization Hobby

Notes

  • Users like api mentioned “The potential for the technology in cancer treatment is what I find most exciting.” Extending that excitement to everyday decisions would resonate.
  • Addresses frustration with “vague safety claims” and could generate community‑driven data input.

AI‑Powered Claim‑Verification Browser Extension for Scientific News

Summary

  • A browser extension that automatically cross‑references headlines with primary literature, regulatory filings, and reputable databases, displaying a credibility score and sourced rebuttals.
  • Core value: Reduce misinformation spread by providing instant, citation‑backed fact‑checking.

Details

Key Value
Target Audience HN readers, journalists, students, policy analysts
Core Feature Real‑time claim parsing, multi‑source retrieval, trust rating, shareable summary cards
Tech Stack Chrome Extension (Manifest V3), GPT‑4 API, ElasticSearch, CrossRef API, React
Difficulty High
Monetization Revenue-ready: Freemium with premium analytics tier ($5/mo)

Notes

  • Commenters often lament “no one backs up assertions” (e.g., timr: “The facts are true. Blaming Trump is the innovation.”). This tool would let users verify claims instantly.
  • Potential to foster a more evidence‑based discussion culture on HN and beyond.

Decentralized Reproducibility Hub for Peer‑Reviewed Studies

Summary

  • A platform where researchers can upload experiment code, datasets, and Dockerized environments, enabling anyone to re‑run analyses with a single click.
  • Core value: Make scientific reproducibility transparent and easy, countering “replicable crisis” doubts.

Details

Key Value
Target Audience Academics, data scientists, journalists, policy makers
Core Feature Version‑controlled containers, automated test suites, badge system for reproducibility status
Tech Stack Flask + FastAPI, Docker, GitLab CI, PostgreSQL, React UI
Difficulty High
Monetization Hobby

Notes

  • HN users discuss “research that can’t be trusted” (e.g., antoniojtorres: “I also lost friends during COVID…” and no‑name‑here about “censorship of content”). A reproducibility hub would directly address trust deficits.
  • Could become a reference point for verifying claims made in health debates.

Plain‑Language Regulatory Decision Explorer

Summary

  • An interactive site that translates FDA, EMA, and CDC approval documents into bite‑size explanations, complete with risk summaries and linked primary sources.
  • Core value: Make regulatory decisions accessible to non‑experts, reducing reliance on “experts say” rhetoric.

Details

Key Value
Target Audience General public, journalists, educators, community organizers
Core Feature Document parsing AI, summarized key points, “what‑if” scenario simulation, citation links
Tech Stack Python (spaCy), Flask, Markdown, ElasticSearch, Tailwind CSS
Difficulty Medium
Monetization Revenue-ready: Tiered API access for schools & NGOs ($0.01 per lookup)

Notes

  • Frequent calls for “clear, simple explanations” (e.g., estearum: “If it is not good enough, then it does not matter…”) and frustration with opaque messaging. This tool would satisfy that need and encourage evidence‑based discourse.

Read Later